Mochida Pharmaceutical Co.,Ltd.

4534

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-03FY2027 Q1

Revenue

1220.4100M JPY

YoY +14.7%

Operating Income

35.6100M JPY

YoY +38.6%

Net Income

91.9100M JPY

YoY +52.5%

EPS

89.8JPY

YoY +68.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

1169.5億円

877.1億円

584.8億円

292.4億円

Rev: 1101.8億円Op: 143.9億円NI: 105.7億円

Rev: 1032.6億円Op: 85.1億円NI: 66.5億円

Rev: 1028.8億円Op: 58億円NI: 45.5億円

Rev: 1051.6億円Op: 81.3億円NI: 56.9億円

Rev: 1169.5億円Op: 101.5億円NI: 79億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income31.8%

Revenue Progress317.200M

Revenue Forecast126000M

Net Income Progress31.800M

Net Income Forecast10000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan